![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Huahai Pharmaceutical Co., Ltd. Linhai Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Irbesartan, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-033 - Rev 03
This Chemical Type CEP, issued on May 05, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2465 associated with this CEP further emphasizes